Management of cardiac implantable electronic devices in cancer patients undergoing radiotherapy. An Italian Association of Hospital Cardiologists (ANMCO) statement

A systematic and multidisciplinary approach is needed to manage cancer patients with a cardiac implantable electronic device undergoing radiation therapy. We report a statement from the Italian Association of Hospital Cardiologists (ANMCO) to provide guidance for clinicians involved in the care continuum of this challenging clinical setting. A comprehensive careful assessment of radiotherapy type, treatment plan and cardiac issues is recommended in order to minimize the risk of device malfunction. Risk stratification before radiation therapy as well as the timing of cardiological assessments during treatment and follow-up strategies are thoroughly discussed. An overview of oncological electrophysiology and radiotherapy-induced damage to devices is also provided. The proposed recommendations represent an expert consensus based on available literature data, guidelines and clinical evidence.

Published by Giornale italiano di cardiologia (2006), 2025. The guideline itself is at the source linked here.

doi.org/10.1714/4531.45340